Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Person writing with pen

Insulin Resistance's Impact on Cognition in Middle Aged Adults from the PREVENT cohort: Interactive Effects with Depression

Bauermeister S. et al, (2023)

Neurodegenerative disease of the brain: a survey of interdisciplinary approaches

Davenport F. et al, (2023), Journal of the Royal Society, Interface, 20

Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.

Low A. et al, (2022), Alzheimers Res Ther, 14

Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.

Dounavi M-E. et al, (2022), J Neurol, 269, 4299 - 4309

Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model.

Liu Q. et al, (2022), BMC Med, 20

Modifiable risk factors for dementia, and awareness of brain health behaviors: Results from the Five Lives Brain Health Ireland Survey (FLBHIS).

Dukelow T. et al, (2022), Front Psychol, 13

Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.

Ng B. et al, (2022), Brain Commun, 4

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.

Sen A. et al, (2021), Trials, 22

An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A Double-Blind, Placebo Controlled, Randomised Cross Over Proof of Concept Study

Sen A. et al, (2021)

Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives.

Rogers JP. et al, (2021), J Neurol Neurosurg Psychiatry

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis

Badenoch J. et al, (2021)

Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study.

Muurling M. et al, (2021), Alzheimers Res Ther, 13

The neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives

Rogers J. et al, (2021)

Brexpiprazole versus placebo or other antidepressive agents for treating depression

Ralovska S. et al, (2021), Cochrane Database of Systematic Reviews, 2021

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge.

Raman B. et al, (2021), EClinicalMedicine, 31

Evaluation of [13N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brain.

Egerton A. et al, (2020), EJNMMI Res, 10

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Raman B. et al, (2020)

Evaluation of [13N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brain.

Egerton A. et al, (2020)

Dementias Platform UK Clinical Studies and Great Minds register: Protocol of a targeted brain health studies re-contact database

Koychev I. et al, (2020)

Dementias platform UK clinical studies and great minds register: protocol of a targeted brain health studies recontact database (vol 10, e040766, 2020)

Koychev I. et al, (2020), BMJ OPEN, 10

Load More

Include forthcoming?